Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Nazerani Hooshmand, T; Pernthaler, B; Szurian, K; Pau, M; Aigner, RM.
18F-FDG PET/CT in the Hyperparathyroidism-Jaw-Tumor Syndrome.
Clin Nucl Med. 2021; 46(6):497-498 Doi: 10.1097/RLU.0000000000003625
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz

Nazerani-Zemann Tina

Pernthaler Birgit

Co-authors Med Uni Graz

Aigner Reingard

Pau Mauro

Szurian Kinga

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Hyperparathyroidism-jaw-tumor syndrome (HPT-JTS) is a rare autosomal dominant disorder. A typical manifestation of HPT-JTS is the association of jaw-ossifying fibroma with primary hyperparathyroidism. Due to its rarity and diversity in its manifestations, it is a challenging diagnosis. A 33-year-old woman was referred due to painful swelling of the right maxilla suggestive of malignancy. The clinical presentations were not conclusive until she underwent F18-fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT). F18-FDG PET/CT proved to be a useful tool to assist the clinicians in visualizing the "bigger picture" and, therefore all manifestation as pieces of "one puzzle." Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Find related publications in this database (Keywords)

F-18 FDG PET/CT

hyperparathyroidism

jaw-tumor syndrome

jaw-ossifying fibroma

parathyroid adenoma

© Med Uni Graz • Imprint